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breast cancer risk, while 11.6% and 14.3% of respondents
believed that they were at higher 5-year and lifetime risk of
breast cancer as compared to an average woman, respectively. A
low but signiﬁcant correlation (0.167, p = 0.045) was found
between respondents’ actual risk and perceived risk of breast
cancer. A large proportion of women (42.6%) were not sure
whether or not they would consume chemopreventive tamoxifen
for breast cancer if advised by their doctor. Only 16.7% women
expressed willingness to consume tamoxifen. No relationship
was found between women’s perceived and actual risk of breast
cancer and their mammography screening behavior or willing-
ness to consume chemopreventive tamoxifen. CONCLUSIONS:
Actual and perceived risk of breast cancer does not seem to be
associated with their screening behavior or willingness to
consume chemopreventive tamoxifen in this population. 
Relatively few women in this population may opt to consume
chemopreventive tamoxifen for reducing their risk of breast
cancer.
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OBJECTIVES: To investigate opioid use in a large sample of
hospice patients and examine differences in opioid use between
cancer and non-cancer patients. METHODS: This project was
conducted with excelleRx, a large hospice pharmacy provider
which contracts with 15% of hospices throughout the US.
Patients included were age 65 or older admitted to hospice
between June 1, 2003 and December 31, 2003. Pharmacy data
through June 30, 2004 was analyzed. Average daily opioid equiv-
alent (ADOE) use was calculated for each patient by converting
total opioid dispensed to morphine equivalents. Associations
between demographic variables and clinical characteristics with
opioid use were examined. Analysis of variance (ANOVA) was
conducted to examine differences in opioid use between cancer
and non-cancer patients. RESULTS: The sample consisted of
43,537 patients representing 4 diagnostic categories: cancer
(46%); heart diagnoses (13%); lung diagnoses excluding lung
cancer (7%); and other (33%). Half (n = 21,767 patients) were
dispensed 1 or more opioids during their hospice stay. For these
patients, the ADOE ranged from 0.03 to 15,305 (mean = 47.0;
SD = 140.0). There was a signiﬁcant inverse correlation (p <
0.0001) between opioid use and age, and male patients were dis-
pensed more opioids (mean = 50.2 ADOE) than females (mean
= 44.1 ADOE, p < 0.05). There were no differences in opioid
use by race, hospice region, or hospice size. ANOVA testing
revealed that opioid use among patients with a hospice diagno-
sis of cancer differed from those without cancer (ADOE = 54.3
cancer vs. 35.0 non-cancer; p < 0.0001), and mean length of
hospice care was shorter for cancer vs. non-cancer patients (43.4
days and 55.2 days, respectively; p < 0.0001). CONCLUSIONS:
Few studies have investigated opioid use in a national hospice
population, in particular, the differences between cancer and
non-cancer patients. Signiﬁcant differences in opioid use were
noted, suggesting the need for further research on how to best
deliver hospice services for this fragile population.
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Prostate cancer is the most common cancer affecting American
men and the second leading cause of cancer deaths in the US.
African-American men have the highest prostate cancer inci-
dence and mortality rates in the world. OBJECTIVE: The
purpose was to investigate differences across racial groups in 
the disease state and treatment of men hospitalized for prostate
cancer. METHODS: Data Source—Florida Agency for Health
Care Administration (AHCA) hospital discharge data for 2002.
Each record represents a patient discharge and includes patient
demographics, diagnoses, procedures and charges for the stay.
Study population includes all patients under 80 years old with 
a primary diagnosis of prostate cancer hospitalized in Florida
during 2002. Analysis: SPSS was used to compare procedures,
co-morbidities, and patient outcomes of discharge status, length-
of-stay and total charges. Chi-Square tests and ANOVA were
used to detect signiﬁcant differences across racial groups.
RESULTS: A total of 5444 men were included in the analysis.
The average age was 64.5 years, with 73% of the patients 
Caucasian, 12% African-American, 11% Hispanic and 4%
other races. Average length of stay was 3.3 days, costing about
$23,000 per stay. Medicare was the primary payer for over 47%
of the hospitalizations. Prostatectomy was performed on 81.5%
of the patients with no signiﬁcant differences across racial
groups. Hypertension was reported in 41.5% of the patients,
occurring signiﬁcantly more in African American patients. On
average, African Americans had signiﬁcantly higher hospital
charges and length of stay, yet were signiﬁcantly younger than
Caucasians. Finally, African Americans were more likely to have
a discharge status of death than any other racial group. CON-
CLUSIONS: African American men hospitalized for prostate
cancer have very different experiences than men of other racial
groups. Further research is necessary to determine why this dis-
parity occurs and how it might be attenuated.
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OBJECTIVE: Colorectal Cancer (CRC), when detected early,
can be treated, reducing morbidity and mortality. In 1997, the
American Cancer Society issued major revisions for CRC screen-
ing guidelines to include new research ﬁndings and improve-
ments in testing accuracy. Research suggests that physicians do
not always follow CRC screening guidelines; lack of knowledge
about appropriate guidelines or guideline changes is often cited
as a barrier. The aim of this systematic review was to examine
studies measuring physician CRC screening knowledge and
related practice patterns. METHODS: A tiered systematic search
(1997–2004) was conducted for studies, irrespective of design,
which were published in peer-reviewed journals through
MEDLINE, Academic Search Elite, CancerLit, CINAHL, and
PsycINFO databases. Tier 1 search combined keywords “knowl-
edge” and “physicians” with “colorectal cancer screening”
which identiﬁed 48 studies. Tier 2 search combined keywords
“practice patterns” and “physicians” with “colorectal cancer
screening” which identiﬁed 52 studies. Tier 3 was a review of
papers identiﬁed in Tiers 1 and 2. Ten studies meeting the
“knowledge” and “practice patterns” inclusion criteria were
retained. RESULTS: Studies reported that a signiﬁcant percent-
age of physicians were performing Fecal Occult Blood Test on
stool samples obtained from Digital Rectal Examination, a
method that often produces false results. Roughly half of physi-
cians were reported to be performing screening tests without
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adequate patient preparation in terms of dietary restrictions
which could impede test accuracy. There were inconsistencies
among physicians regarding when in a patient’s life to initiate
screening, and at what age to discontinue screening. CONCLU-
SIONS: This systematic review of ten included studies reﬂected
considerable knowledge gaps among physicians, which could
contribute to reasons for inadequate screening rates. Provider
education about CRC screening should emphasize guidelines
regarding when to start screening, frequency rates for screening
with given modalities, and particular techniques and precautions
that should be used to perform screening.
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OBJECTIVE: Log transformation reduces robustness by focus-
ing on symmetry. It improves precision and it diminishes the
outlier effect. One big disadvantage of log models is retrans-
formation problems. Although smearing methods provides 
non-parametric way to transform estimated costs, it fails to
adjust heteroskedasticity especially if the form of heteroskedas-
ticity is not known. In this paper, we propose a method where
we can apply transformation accounting for heteroskedasticity.
We compare our results with smearing estimators and general-
ized linear model (GLM) estimators. METHODS: Two form of
heteroskedasticity is considered: 1) The heteroskedasticity is
known up to a multiple constant. We used generalized least
squares (GLS) estimator for correcting heteroskedasticity: and 2)
The form of heteroskedasticity is unknown. If this is the case,
feasible GLS method is used. After correcting for heteroskedas-
ticity smearing estimates is applied for the transformed equations
to do the retransformation. Medstat Market Scan data is used
to show the application. Cost level estimators are compared:
OLS estimation, smearing transformation assumed no het-
eroskedasticity, smearing transformation with heteroskedasticity,
GLM estimators where the family is gaussian with logarithmic
link function. RESULTS: Estimation methods yield that log scale
residuals were heavy tailed. White Test suggested the presence of
heteroskedascity. The graph of squared residuals on disease stage
levels show that variance is increasing with an increased level of
stage levels. Park test suggested that if GLM is chosen, gaussian
family should be chosen. Comparisons of the retransformed
costs yield that smearing transformation after accounting for
least deviation yielded least minimum square errors. CONCLU-
SION: We attempted to solve the biggest disadvantage of log
transformed cost estimation by proposing two stage estimation
procedure where at the ﬁrst stage GLS or feasible GLS is used to
correct for possible heteroskedasticity (depending on the form 
of heteroskedasticity), at the second stage smearing method is
applied to transformed equation.
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OBJECTIVE: Censoring is common problem with medical count
data. Estimation over only uncensored patients yields bias
toward the patients who have shorter survival time since patients
who have longer survival times are high likely to be censored.
Standard survival analysis is not applicable since the number of
visits during the study time and after censoring time is not inde-
pendent. The objective of this paper is to propose a method,
which can be applied to censored count data. METHOD: The
proposed method ﬁrst estimates the probability of censoring 
by using logit model. Then, second stage involves estimating
weighted Poisson regression where weights are calculated as
inverse of estimated probability of censoring. We show that the
resulting estimators are consistent. Standard errors from second
stage are not valid and should be adjusted for ﬁrst stage estima-
tion. We estimate the errors by using bootstrapping techniques.
RESULTS: Medstat Market Scan data is used as an application
of the method. Total hospitalization days after a year of initial
diagnoses is estimated. Patients who are diagnosed less than a
year before the end of study period are considered as censored.
After using inverse probability weighted poisson regression, we
also estimate the total hospitalization days by dropping the
patients whose visits are censored. A test is proposed to compare
the coefﬁcients. We found that the difference in coefﬁcients are
signiﬁcant (p < 0.0004). CONCLUSION: This paper presents a
method for testing and correcting for possible sample selection
bias for cross sectional data. In our application we assessed the
inﬂuence of explanatory variables, such as patient and clinical
characteristics, on inpatient visits of asthma two years following
diagnosis after accounting for possible selection bias due to 
censoring. We applied poisson and our proposed method and 
to show that failing to do the adjustments yield different 
estimators.
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OBJECTIVES: To assess inter-rater agreement of Health Utilities
Index (HUI) measurements in survivors of cancer during child-
hood in Honduras, El Salvador, Nicaragua and Panama.
METHODS: Patients and their parents completed a Spanish-
language interviewer-administered HUI questionnaire. Physi-
cians answered the Spanish-language self-complete questionnaire
version. Primary analyses of agreement between patients and
parents, and patients and physicians, for HUI3 single-attribute
and overall health-related quality of life (HRQL) utility scores
was measured using single-measure one-way intra-class correla-
tion coefﬁcient (ICC). Secondary analyses used the two-way
mixed model ICC, Pearson’s r and concordance correlation coef-
ﬁcient. Differences in mean scores > 0.05 are considered clini-
cally important. RESULTS: Of 211 patients surveyed (aged 3.4
to 25.8 years at time of study, 56% male), there were 191
patient/parent pairs of complete HUI assessments and 192
patient/physician pairs. There was moderate or better agreement
(ICC > 0.41, p < 0.001) between both pairs of raters for vision,
hearing, speech and ambulation. Agreement was less than mod-
erate (ICC < 0.41) for pain (p < 0.01), cognition (p < 0.01) and
emotion (p < 0.05). Statistically signiﬁcant (p < 0.001) and clin-
ically important differences were observed within both sets of
paired groups for cognition and emotion, with lower mean
scores for patients. For overall HRQL, agreement was moderate
between patients and parents but less than moderate between
patients and physicians. The mean overall HRQL score was sig-
niﬁcantly lower statistically (p < 0.01) and clinically for patients
than both parents (diff = 0.094), and physicians (diff = 0.159).
Secondary analyses yielded similar results. CONCLUSIONS:
Parent and physician reports should not be considered inter-
changeable with patient assessments, especially for aspects of
health not readily observable. There were important differences
between patients and parents and physicians in emotion, cogni-
